Get in touch.

List of contacts

Do you have any questions about ZB MED`s services or the range of literature we offer? Or maybe you need some tips on how to run searches in LIVIVO?

Contact

info@zbmed.de
Phone: +49 (0)221 999 892 240

Cologne Site

Medicine and Health

Address:
ZB MED – Information Centre for Life Sciences
Gleueler Straße 60
50931 Cologne (Köln)
Germany

Bonn Site

Nutritional, Environmental and Agricultural Sciences

Address:
ZB MED – Information Centre for Life Sciences
Friedrich-Hirzebruch-Allee 4
53115 Bonn
Germany

InfoCenter

INFORMATION.

KNOWLEDGE.
LIFE.

An infrastructure and research centre for data and information in the life sciences.

Studying or working in life sciences?

We've got the research tools you need.

Conference detail

Conference details

19.03.2024 - 21.03.2024

The Tumour Ecosystem: Cellular Interactions and Therapeutic Opportunities

Location
Bergamo
Contact

Hannah Barrs <hannah.barrs@eacr.org>

Country
Italy
Shortinfo

This meeting will cover the latest exciting breakthroughs on multiple aspects of the tumour microenvironment, including the intricate interactions of cancer cells with the immune system and with specific stromal cells in multiple organs. We will also highlight novel insights into tumour-host interactions including changes in metabolism, the nervous system and response to therapy.


Join us to hear from world experts who are at the forefront of the tumour microenvironment field, sharing their latest discoveries and insights about this cutting-edge research and its implications for novel cancer therapies. Featured topics include the role of inflammation and immunity in tumour progression and metastasis, organ-specific stromal cells that support tumour progression, metabolic changes in the tumour microenvironment, tumour-host interactions in response to therapy, cancer interactions with the nervous system, and dormancy and metastasis.



The target audience for this conference is: scientists, postdocs, and graduate students interested in multiple aspects of cancer biology, immunology, and therapeutics; industry scientists interested in translational research and novel therapeutic approaches; and journal editors interested in cutting-edge cancer biology.